Beam Therapeutics is a Biotech company based in Cambridge. It has raised $1B in total funding. Latest round: IPO.
Beam Therapeutics funding overview
Beam Therapeutics is a Biotech company based in Cambridge. Beam Therapeutics has raised $1B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in February 2020. The round record for Beam Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include F-Prime Capital Partners, ARCH Venture Partners. 2 distinct backers are named across the disclosed rounds.
Beam Therapeutics at a glance
Total raised
$1B
Latest round
IPO
Latest round date
February 2020
Industry
Biotech
Headquarters
Cambridge
Notable investors
F-Prime Capital Partners, ARCH Venture Partners
Frequently asked about Beam Therapeutics funding
How much has Beam Therapeutics raised?
Beam Therapeutics has raised $1B in total disclosed funding across the rounds on record.
Who has invested in Beam Therapeutics?
F-Prime Capital Partners, ARCH Venture Partners are named among the investors backing Beam Therapeutics.
What was the latest Beam Therapeutics funding round?
The most recent disclosed round is an IPO, announced in February 2020.
Where is Beam Therapeutics based?
Beam Therapeutics is based in Cambridge.
What sector does Beam Therapeutics operate in?
Beam Therapeutics is tracked under Biotech from Cambridge, with $1B in disclosed funding.
When did Beam Therapeutics last raise?
The last disclosed Beam Therapeutics round closed in February 2020 at IPO.
Beam Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.
